Moderna, Inc.
MRNA
$125.59
$14.1312.68%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 217.00M | -3.63B | -1.38B | 79.00M | 1.47B |
| Total Depreciation and Amortization | 202.00M | 249.00M | 92.00M | 78.00M | 80.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -46.00M | 1.60B | -201.00M | -238.00M | -36.00M |
| Change in Net Operating Assets | 249.00M | 182.00M | 574.00M | -1.14B | 153.00M |
| Cash from Operations | 622.00M | -1.60B | -915.00M | -1.23B | 1.66B |
| Capital Expenditure | -220.00M | -140.00M | -234.00M | -113.00M | -92.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | 0.00 | -85.00M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -318.00M | 929.00M | 2.18B | 2.21B | -956.00M |
| Cash from Investing | -538.00M | 789.00M | 1.94B | 2.01B | -1.05B |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -124.00M | -65.00M | -56.00M | -25.00M | -61.00M |
| Issuance of Common Stock | 15.00M | 7.00M | 16.00M | 9.00M | 25.00M |
| Repurchase of Common Stock | 0.00 | -- | -628.00M | -526.00M | -402.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -109.00M | -58.00M | -668.00M | -542.00M | -438.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.00M | -869.00M | 361.00M | 244.00M | 176.00M |
